Samit Hirawat - Net Worth and Insider Trading
Samit Hirawat Net Worth
The estimated net worth of Samit Hirawat is at least $3 Million dollars as of 2025-04-28. Samit Hirawat is the EVP,Chief Med.Offr.,Drug Dev. of Bristol-Myers Squibb Co and owns about 63,932 shares of Bristol-Myers Squibb Co (BMY) stock worth over $3 Million. Details can be seen in Samit Hirawat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samit Hirawat has not made any transactions after 2025-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Samit Hirawat
Samit Hirawat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samit Hirawat owns 1 companies in total, including Bristol-Myers Squibb Co (BMY) .
Click here to see the complete history of Samit Hirawat’s form 4 insider trades.
Insider Ownership Summary of Samit Hirawat
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
BMY | Bristol-Myers Squibb Co | 2025-02-14 | Chief Medical Offr. & Drug Dev. |
Samit Hirawat Latest Holdings Summary
Samit Hirawat currently owns a total of 1 stock. Samit Hirawat owns 63,932 shares of Bristol-Myers Squibb Co (BMY) as of February 14, 2025, with a value of $3 Million.
Latest Holdings of Samit Hirawat
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMY | Bristol-Myers Squibb Co | 2025-02-14 | 63,932 | 48.27 | 3,085,998 |
Holding Weightings of Samit Hirawat
Samit Hirawat Form 4 Trading Tracker
According to the SEC Form 4 filings, Samit Hirawat has made a total of 2 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 1,823 shares on February 14, 2025, which cost Samit Hirawat around $100,000.
Insider Trading History of Samit Hirawat
- 1
Samit Hirawat Trading Performance
GuruFocus tracks the stock performance after each of Samit Hirawat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samit Hirawat is 8.52%. GuruFocus also compares Samit Hirawat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samit Hirawat within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samit Hirawat's insider trading performs compared to the benchmark.
Performance of Samit Hirawat
Samit Hirawat Ownership Network
Ownership Network List of Samit Hirawat
Ownership Network Relation of Samit Hirawat

Samit Hirawat Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Samit Hirawat is the Chief Medical Offr. & Drug Dev. of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Samit Hirawat made 2 insider transaction in Bristol-Myers Squibb Co (BMY) with a net purchase of 3,653. Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 7,071 shares made by Christopher S. Boerner , a net purchase of 8,500 shares made by Samuels Theodore R. Ii , and a net sale of 700 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 3,823 shares, with a net purchase of 3,823 shares. During the past 18 months, 700 shares of Bristol-Myers Squibb Co (BMY) were sold and 19,224 shares were bought by its insiders, resulting in a net purchase of 18,524 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Samit Hirawat Mailing Address
Above is the net worth, insider trading, and ownership report for Samit Hirawat. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Samit Hirawat's mailing address is: Princeton Nj 08543.